Inferra AI / Company / LMRI
Lumexa Imaging Holdings, Inc.
LMRI · Health Care
Last earnings Aug 12, 2026
Key results
Consolidated revenuequarter
$252.5 million
Consolidated revenues of $252.5 million, an increase of 3.1% from $245.0 million System-wide revenue growth of 4.0% Same center advanced volume growth: 5.6% for both consolidated and system-wide
SEC original ↗Lumexa Imaging Holdings, Inc. — Earnings release (8-K exhibit)EX-99May 12, 2026
System-wide revenuequarter
3.1%
Consolidated revenues of $252.5 million, an increase of 3.1% from $245.0 million System-wide revenue growth of 4.0% Same center advanced volume growth: 5.6% for both consolidated and system-wide
SEC original ↗Lumexa Imaging Holdings, Inc. — Earnings release (8-K exhibit)EX-99May 12, 2026
Net incomequarter
$1.7 million
Net income of $1.7 million as compared to net loss of $7.7 million Adjusted EBITDA of $51.2 million as compared to $51.0 million
SEC original ↗Lumexa Imaging Holdings, Inc. — Earnings release (8-K exhibit)EX-99May 12, 2026
AI analysis
Q1 2026 · reported May 12, 2026
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Headline figures
| Metric | Q1 2026 | Prior qtr | Year ago |
|---|---|---|---|
| Consolidated revenue | $252.5 million | — | — |
| System-wide revenue | 3.1% | — | — |
| Net income | $1.7 million | — | — |
Guidance · company-stated
Direction: Reiterated
“(At the midpoint of guidance, the addition of these costs lowers Adjusted EBITDA growth for 2026 versus 2025 from 7% to 4%) Adjusted EPS of $0.71 to $0.77 per share Lumexa Imaging Earnings Conference Call and Webcast Lumexa Imaging will host a conference call to discuss its first quarter 2026 results, as well as its 2026 outlook, on May 12, 2026 at 5:00 p.”
“htm EX-99.1 EX-99.1 Exhibit 99.1 Lumexa Imaging Announces First Quarter 2026 Results RALEIGH, NORTH CAROLINA, May 12, 2026 Lumexa Imaging (Nasdaq: LMRI), one of the nation s largest providers of outpatient imaging services, today announced results for the first quarter ended March 31, 2026, and reiterated full year 2026 guidance.”
Classified from the release's primary full-year outlook statement.
Capital allocation
(5) Consists of other costs related to debt financing, certain de novo start-up costs related to outpatient imaging centers and certain exit costs related to closed outpatient imaging centers.
$ 406.4 million of the net proceeds were used to pay down a portion of the Company's outstanding borrowings.
Event summary
Lumexa Imaging Holdings, Inc. Q1 2026 — Consolidated revenues of $252.5 million, an increase of 3.1% from $245.0 million System-wide revenue growth of 4.0% Same center advanced volume growth: 5.6% for both consolidated and system-wide
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
Direction: Reiterated
EPS: “(At the midpoint of guidance, the addition of these costs lowers Adjusted EBITDA growth for 2026 versus 2025 from 7% to 4%) Adjusted EPS of $0.71 to $0.77 per share Lumexa Imaging Earnings Conference Call and Webcast Lumexa Imaging will host a conference call to discuss its first quarter 2026 results, as well as its 2026 outlook, on May 12, 2026 at 5:00 p.”
Company outlook — Reiterated (“reiterated”)
“htm EX-99.1 EX-99.1 Exhibit 99.1 Lumexa Imaging Announces First Quarter 2026 Results RALEIGH, NORTH CAROLINA, May 12, 2026 Lumexa Imaging (Nasdaq: LMRI), one of the nation s largest providers of outpatient imaging services, today announced results for the first quarter ended March 31, 2026, and reiterated full year 2026 guidance.”
EPS — Lowered (“lowers”)
“(At the midpoint of guidance, the addition of these costs lowers Adjusted EBITDA growth for 2026 versus 2025 from 7% to 4%) Adjusted EPS of $0.71 to $0.77 per share Lumexa Imaging Earnings Conference Call and Webcast Lumexa Imaging will host a conference call to discuss its first quarter 2026 results, as well as its 2026 outlook, on May 12, 2026 at 5:00 p.”
Classified from the release's primary full-year outlook statement.
Capital allocation
(5) Consists of other costs related to debt financing, certain de novo start-up costs related to outpatient imaging centers and certain exit costs related to closed outpatient imaging centers.
SEC original ↗Lumexa Imaging Holdings, Inc. — Earnings release (8-K exhibit)EX-99May 12, 2026
$ 406.4 million of the net proceeds were used to pay down a portion of the Company's outstanding borrowings.
SEC original ↗Lumexa Imaging Holdings, Inc. — 10-Q Quarterly report10-QAug 13, 2026
The two-class method determines net income (loss) per common share for each class of common share and participating securities according to dividends declared or accumulated and participation rights in undistributed 10 LUMEXA IMAGING holdings, inc.
SEC original ↗Lumexa Imaging Holdings, Inc. — 10-Q Quarterly report10-QAug 13, 2026
The two-class method requires income available to common stockholders for the period to be allocated between common shares and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed.
SEC original ↗Lumexa Imaging Holdings, Inc. — 10-Q Quarterly report10-QAug 13, 2026
Basic net income (loss) per common share is computed by dividing the net income (loss) by the weighted-average number of common shares outstanding during the period, less shares subject to repurchase.
SEC original ↗Lumexa Imaging Holdings, Inc. — 10-Q Quarterly report10-QAug 13, 2026
Holdings LLC Incentive Units are considered participating securities prior to the Company s Equity Reorganization that occurred (See Note 1) in connection with the IPO because they contractually entitled the holders of such units to participate in dividends.
SEC original ↗Lumexa Imaging Holdings, Inc. — 10-Q Quarterly report10-QAug 13, 2026
Strategy & priorities
In Q1, we delivered several meaningful achievements to kick off a year of executing on our strategic priorities.
SEC original ↗Lumexa Imaging Holdings, Inc. — Earnings release (8-K exhibit)EX-99May 12, 2026
We are also announcing tonight four additional Lumexa Imaging centers including two strategic tuck-in acquisitions plus two de novos.
SEC original ↗Lumexa Imaging Holdings, Inc. — Earnings release (8-K exhibit)EX-99May 12, 2026
Zulla continued, With a large addressable market, and strong demand tailwinds plus a focused strategy centered on same-center growth, geographic expansion, and advanced imaging, we believe Lumexa Imaging is well positioned to deliver sustained, profitable growth while expanding access to high-quality, lower-cost imaging for patients, providers, and payors.
SEC original ↗Lumexa Imaging Holdings, Inc. — Earnings release (8-K exhibit)EX-99May 12, 2026
We use Adjusted EBITDA and Adjusted EPS, in conjunction with GAAP financial measures, as an integral part of managing our business and to, among other things: (i) monitor and evaluate the performance of our business operations and financial performance; (ii) facilitate internal comparisons of the historical operating performance of our business operations; (iii) review and assess the operating performance of our management team; and (iv) analyze and evaluate financial and strategic planning decisions regarding future operations and annual operating budgets.
SEC original ↗Lumexa Imaging Holdings, Inc. — Earnings release (8-K exhibit)EX-99May 12, 2026
In some cases, you can identify forward-looking statements because they contain words such as anticipate, believe, contemplate, continue, could, estimate, expect, intend, may, plan, potential, predict, project, should, target, or will, or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions.
SEC original ↗Lumexa Imaging Holdings, Inc. — Earnings release (8-K exhibit)EX-99May 12, 2026
Risks & headwinds
We have not reconciled our Adjusted EBITDA or Adjusted EPS guidance to their most directly comparable GAAP measures because we do not and are not able to provide guidance for those GAAP measures due to the uncertainty and potential variability of certain reconciling items, including transaction costs, severance and executive recruiting.
SEC original ↗Lumexa Imaging Holdings, Inc. — Earnings release (8-K exhibit)EX-99May 12, 2026
Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including but not limited to those risk factors identified in the Risk Factors and Management s Discussion and Analysis of Financial Condition and Results of Operations sections of our Annual Report on Form 10-K for the year ended December 31, 2025, each as filed with the Securities and Exchange Commission (SEC).
SEC original ↗Lumexa Imaging Holdings, Inc. — Earnings release (8-K exhibit)EX-99May 12, 2026
(4) Consists of litigation and settlement costs for matters not related to core operations.
SEC original ↗Lumexa Imaging Holdings, Inc. — Earnings release (8-K exhibit)EX-99May 12, 2026
Legal Proceedings 49 Item 1A.
SEC original ↗Lumexa Imaging Holdings, Inc. — 10-Q Quarterly report10-QAug 13, 2026
AND SUBSIDIARIES Notes to Consolidated Financial Statements (Continued) The Company s percentage of accounts receivable by payor class was as follows: JUNE 30, DECEMBER 31, 2026 2025 Commercial insurance 41 % 42 % Attorney liens 33 36 Government Medicare 13 12 Government Medicaid 4 3 Self-pay 1 1 Other third-party payors 8 6 100 % 100 % Attorney liens represent patient accounts receivable related to ongoing litigation between third parties, in which the Company has been contracted to provide imaging services.
SEC original ↗Lumexa Imaging Holdings, Inc. — 10-Q Quarterly report10-QAug 13, 2026
The Company is not directly involved in the ongoing litigation.
SEC original ↗Lumexa Imaging Holdings, Inc. — 10-Q Quarterly report10-QAug 13, 2026
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
15 documentsEarnings releases
4 documentsPresentations
0 documentsNo presentations for Lumexa Imaging Holdings, Inc. are held in this edition of the library.
Transcripts
0 documentsNo transcripts for Lumexa Imaging Holdings, Inc. are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.